| Merakey New Jersey | |
|
312 Telegraph Rd Alloway NJ 08001-2017 | |
| (215) 836-3131 | |
| (215) 273-5975 |
| Full Name | Merakey New Jersey |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 312 Telegraph Rd, Alloway, New Jersey |
| Authorized Official Name and Position | Norman E Tilson (CORP SR. DIRECTOR OF BUSINESS OPS) |
| Authorized Official Contact | 2158363131 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Merakey New Jersey 620 Germantown Pike Lafayette Hill PA 19444-1810 Ph: (215) 836-3131 | Merakey New Jersey 312 Telegraph Rd Alloway NJ 08001-2017 Ph: (215) 836-3131 |
| NPI Number | 1609433374 |
|---|---|
| Provider Enumeration Date | 05/28/2019 |
| Last Update Date | 01/29/2024 |
| Certification Date | 01/29/2024 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609433374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.
The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).
Sara Piccirillo, PhD, is passionate about finding a way to beat glioblastoma, the most aggressive type of brain cancer.
St. Jude Children's Research Hospital scientists have a lead on reducing life-threatening respiratory problems in infants born to women who develop the liver disorder intrahepatic cholestasis of pregnancy (ICP).
› Verified 7 days ago